Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor-induced adhesion molecule expression on eosinophils by p38 mitogen-activated protein kinase and nuclear factor-[kappa] B

Am J Respir Cell Mol Biol. 2003 Jul;29(1):133-47. doi: 10.1165/rcmb.2002-0289OC. Epub 2003 Feb 14.

Abstract

We investigated the intracellular signaling mechanisms for cytokine interleukin (IL)-3, IL-5, or granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced expression of adhesion molecules including very late antigen 4 (CD49 d), macrophage antigen-1 (CD11b), leukocyte function-associated antigen-1 (CD11a/CD18), intercellular adhesion molecule (ICAM)-1, and ICAM-3 on eosinophils. The expression of adhesion molecules and nuclear factor (NF)-kappaB pathway was measured by flow cytometry and cDNA expression array, respectively. The phosphorylation of inhibitor kappaB-alpha and p38 mitogen-activated protein kinase (MAPK) was detected by Western blot, whereas NF-kappaB activity was measured by electrophoretic mobility shift assay. IL-3, IL-5, and GM-CSF could enhance p38 MAPK and NF-kappaB activity and induce ICAM-1, CD11b, and CD18 expressions on eosinophils. They could suppress ICAM-3 expression, but had no effect on CD49 d expression. Either SB 203580 or MG-132 was able to offset the cytokine-induced expression of ICAM-1. Only SB 203580 could reverse the effect on CD11b, CD18, and ICAM-3 expressions. Therefore, the expression of ICAM-1 might involve both p38 MAPK and NF-kappaB activities, whereas the regulation of CD11b, CD18, and ICAM-3 expressions might be mediated through p38 MAPK but not NF-kappaB. These cytokines therefore play a crucial role, via the p38 MAPK and NF-kappaB pathways, in the expression of important adhesion molecules on eosinophils in allergic inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD11b Antigen / metabolism
  • CD18 Antigens / metabolism
  • Cell Adhesion Molecules / drug effects
  • Cell Adhesion Molecules / genetics
  • Cell Adhesion Molecules / metabolism*
  • Cells, Cultured
  • Enzyme Inhibitors / pharmacology
  • Eosinophils / drug effects
  • Eosinophils / metabolism*
  • Gene Expression Regulation / drug effects
  • Granulocyte-Macrophage Colony-Stimulating Factor / metabolism
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Humans
  • Imidazoles / pharmacology
  • Integrin alpha4 / metabolism
  • Interleukin-3 / metabolism
  • Interleukin-3 / pharmacology*
  • Interleukin-5 / metabolism
  • Interleukin-5 / pharmacology*
  • Leupeptins / pharmacology
  • Mitogen-Activated Protein Kinases / drug effects
  • Mitogen-Activated Protein Kinases / metabolism*
  • NF-kappa B / drug effects
  • NF-kappa B / metabolism*
  • Phosphorylation / drug effects
  • Pyridines / pharmacology
  • Signal Transduction
  • p38 Mitogen-Activated Protein Kinases

Substances

  • CD11b Antigen
  • CD18 Antigens
  • Cell Adhesion Molecules
  • Enzyme Inhibitors
  • Imidazoles
  • Interleukin-3
  • Interleukin-5
  • Leupeptins
  • NF-kappa B
  • Pyridines
  • Integrin alpha4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde